1752 Stock Overview
Engages in the manufacturing, processing, trading, import, and export of pharmaceuticals and medical devices in Taiwan and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Nang Kuang Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$42.70 |
| 52 Week High | NT$61.90 |
| 52 Week Low | NT$40.10 |
| Beta | 0.24 |
| 11 Month Change | -1.61% |
| 3 Month Change | -6.36% |
| 1 Year Change | -18.82% |
| 33 Year Change | 16.19% |
| 5 Year Change | -5.11% |
| Change since IPO | 152.00% |
Recent News & Updates
Recent updates
Nang Kuang Pharmaceutical Co., Ltd.'s (TWSE:1752) 28% Price Boost Is Out Of Tune With Earnings
May 22
Some Investors May Be Willing To Look Past Nang Kuang Pharmaceutical's (TWSE:1752) Soft Earnings
Apr 02Nang Kuang Pharmaceutical (GTSM:1752) Has A Pretty Healthy Balance Sheet
Mar 20Should You Or Shouldn't You: A Dividend Analysis on Nang Kuang Pharmaceutical Co., Ltd. (GTSM:1752)
Mar 03Declining Stock and Decent Financials: Is The Market Wrong About Nang Kuang Pharmaceutical Co., Ltd. (GTSM:1752)?
Feb 13
Nang Kuang Pharmaceutical's (GTSM:1752) Stock Price Has Reduced 17% In The Past Five Years
Jan 26Estimating The Fair Value Of Nang Kuang Pharmaceutical Co., Ltd. (GTSM:1752)
Jan 08Here's How We Evaluate Nang Kuang Pharmaceutical Co., Ltd.'s (GTSM:1752) Dividend
Nov 29Shareholder Returns
| 1752 | TW Pharmaceuticals | TW Market | |
|---|---|---|---|
| 7D | -3.3% | -2.8% | -3.4% |
| 1Y | -18.8% | 7.2% | 30.2% |
Return vs Industry: 1752 underperformed the TW Pharmaceuticals industry which returned 7.2% over the past year.
Return vs Market: 1752 underperformed the TW Market which returned 30.2% over the past year.
Price Volatility
| 1752 volatility | |
|---|---|
| 1752 Average Weekly Movement | 1.8% |
| Pharmaceuticals Industry Average Movement | 3.6% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in TW Market | 8.0% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 1752 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 1752's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1963 | n/a | Yu-Bei Wang | www.nangkuang.com.tw |
Nang Kuang Pharmaceutical Co., Ltd. engages in the manufacturing, processing, trading, import, and export of pharmaceuticals and medical devices in Taiwan and internationally. The company provides parenterals, aseptic parenterals, lyophilized injections, pre-filled syringes, and pre-mixed IV infusion bags, as well as tablets, capsules, topical products, and oral suspensions. It also offers various products in the areas of cardiovascular system, gastrointestinal system, nervous system, alimentary and metabolism, blood, antineoplastic and immunomodulatory, musculo-skeletal system, respiratory system, dermatological, genito-urinary and sex hormone, systemic hormone, systemic antibacterial, and cosmetics, as well as hospital solutions.
Nang Kuang Pharmaceutical Co., Ltd. Fundamentals Summary
| 1752 fundamental statistics | |
|---|---|
| Market cap | NT$4.31b |
| Earnings (TTM) | NT$122.15m |
| Revenue (TTM) | NT$2.14b |
35.3x
P/E Ratio2.0x
P/S RatioIs 1752 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1752 income statement (TTM) | |
|---|---|
| Revenue | NT$2.14b |
| Cost of Revenue | NT$1.43b |
| Gross Profit | NT$710.25m |
| Other Expenses | NT$588.10m |
| Earnings | NT$122.15m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.21 |
| Gross Margin | 33.24% |
| Net Profit Margin | 5.72% |
| Debt/Equity Ratio | 21.8% |
How did 1752 perform over the long term?
See historical performance and comparison